BLACK WEEKSFlakonai −15% · rinkiniai −10% · kita −5%su koduNemokamas siuntimas Vokietijoje nuo €200

Šis puslapis išverstas automatiškai ir jame gali būti klaidų. Ar lietuvių kalba yra jūsų gimtoji? Mielai sulauksime jūsų atsiliepimų ir pataisymų.Siųsti atsiliepimą

The Peptide Desk The Peptide Desk
Tirzepatide Oral, produkto nuotrauka

Laboratorijos ataskaita

PDF
Ištirta
Ištirta
Tirzepatide Oral 500mcg × 25 Tabs
Laboratorija
Analiza Białek
Data
October 2026
Rezultatas
568.25 mcg per tablet (500 mcg label)
Užsakymo nr.
Slaptažodis

Ištirta nepriklausomai, su slaptažodžiu galima patikrinti tiesiogiai laboratorijoje.

GLP-1 Oral

Tirzepatide Oral

GLP-1 Oral

Užsakymas

Vieneto kaina - Nemokamas siuntimas Vokietijoje nuo 200 € Black Weeks metu
  • DHL su sekimu
  • Diskreti pakuotė

4.6 iš 5 TrustpilotAtsiliepimų: 73

Taip pat ieškoma kaip: Tirzepatid Oral · Tirzepatid Tabletten

Trumpai

Tirzepatide Oral skaičiais

Pagrindiniai rodikliai iš mūsų žinyno. Vilkite tašką kreive, kad pamatytumėte, kiek lieka po vienos dozės, pagal skaičiavimą.

Visas žinyno įrašas

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~5 days

Half-life ~5 days
After 10 days: 25 %
Day 1, next dose87 %Day 550 %Day 1025 %Day 1512.5 %Day 253.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

~5days

molecule, still taken daily

Class
Dual GIP / GLP-1 agonistoral
Use
Once daily in the morningfasted, with a little water
Form
Tablet500mcg, 25 per pack
Sizes
500mcg/25tabs1 size in the shop

Žinios

Viskas apie Tirzepatide Oral

FAQ

Dažnai užduodami klausimai

Šaltiniai kiekvienam atsakymui: žinyno įrašas

Dar turite klausimų?

Parašykite mums, mūsų komanda jums padės.

Is tirzepatide approved as a tablet?

No. The compound is approved only as an injection, since 2022 according to ChEMBL. ClinicalTrials.gov lists no trial of oral tirzepatide, as of 26 October 2026.

How much of a tablet reaches the blood?

For tirzepatide this has not been measured in humans. For oral semaglutide, the only approved GLP-1 peptide to swallow, it is about 0.8 percent. Absorption varies by 137 percent from day to day and evens out to about 33 percent with daily intake.

Is there research on a tirzepatide tablet?

Yes, but only preclinical. A 2026 study developed a tablet with sodium caprate as an absorption enhancer. In a cell model permeability improved, in rats and beagle dogs blood levels were measurable.

Why does fasting matter so much?

With oral semaglutide absorption depended mainly on the fasting time after the tablet and on the water volume. Waiting longer raised it, more water lowered it. Absorption takes place directly in the stomach close to the tablet.

What do the trials on the compound itself show?

With the weekly injection weight fell by 15.0 to 20.9 percent after 72 weeks in SURMOUNT-1, by 3.1 percent on placebo. These figures apply to the injection and cannot be transferred to the tablet.

Which side effects are described?

For the compound mainly gastrointestinal effects such as nausea, vomiting, diarrhoea and reduced appetite, depending on the dose. In SURMOUNT-1 4.3 to 7.1 percent stopped because of side effects, 2.6 percent on placebo. There are no human data for the tablet itself.

Susiję

Susiję produktai